Association between atherosclerosis and osteoporosis, the role of vitamin D

被引:63
作者
Stojanovic, Olivera Llic [1 ]
Lazovic, Milica [1 ]
Lazovic, Marko [2 ]
Vuceljic, Marina [3 ]
机构
[1] Inst Rehabil, Belgrade 11000, Serbia
[2] Clin Ctr Nis, Clin Cardiovasc Dis, Belgrade, Serbia
[3] Biochem Lab ALLABO, Belgrade, Serbia
关键词
vitamin D deficiency; low bone density; cardiovascular disease; fracture risk; BONE-MINERAL DENSITY; COA REDUCTASE INHIBITORS; 1,25-DIHYDROXYVITAMIN D-3; CARDIOVASCULAR-DISEASE; D DEFICIENCY; AORTIC CALCIFICATION; LIPID PROFILE; FRACTURE RISK; LIPOPROTEIN; CALCIUM;
D O I
10.5114/aoms.2011.22066
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The latest data support the correlation of atherosclerosis and osteoporosis, indicating the parallel progression of two tissue destruction processes with increased fatal and non-fatal coronary events, as well as higher fracture risk. Vitamin D inadequacy associated with low bone mineral density increases fall and fracture risk, leads to secondary hyperparathyroidism, calcifies coronary arteries and significantly increases cardiovascular disease. Randomized clinical trial evidence related to extraskeletal vitamin D outcomes was limited and generally uninformative. A recent recommendation on vitamin D dietary requirements for bone health is 600 IU/d for ages 1-70 years and 800 IU/d for 71 years and older, corresponding to a serum 25-hydroxyvitamin D level of at least 20 ng/ml (50 nmol/l). Further large randomized controlled trials are needed to reassess laboratory ranges for 25-hydroxyvitamin D in both diseases, in order to avoid under- and over-treatment problems, and completely clarify the relationship between atherosclerosis and osteoporosis.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 82 条
[51]   Osteoporosis and cardiovascular disease - Brittle bones and boned arteries, is there a link? [J].
McFarlane, SI ;
Muniyappa, R ;
Shin, JJ ;
Bahtiyar, G ;
Sowers, JR .
ENDOCRINE, 2004, 23 (01) :1-10
[52]   HMG-CoA reductase inhibitors and the risk of fractures [J].
Meier, CR ;
Schlienger, RG ;
Kraenzlin, ME ;
Schlegel, B ;
Jick, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (24) :3205-3210
[53]   The protective effects of estrogen on the cardiovascular system [J].
Mendelsohn, ME ;
Karas, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (23) :1801-1811
[54]   Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women [J].
Miyao, M ;
Morita, H ;
Hosoi, T ;
Kurihara, H ;
Inoue, S ;
Hoshino, S ;
Shiraki, M ;
Yazaki, Y ;
Ouchi, Y .
CALCIFIED TISSUE INTERNATIONAL, 2000, 66 (03) :190-194
[55]   Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women [J].
Montalcini, T ;
Emanuele, V ;
Ceravolo, R ;
Gorgone, G ;
Sesti, G ;
Perticone, F ;
Pujia, A .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (02) :266-269
[56]   Stimulation of bone formation in vitro and in rodents by statins [J].
Mundy, G ;
Garrett, R ;
Harris, S ;
Chan, J ;
Chen, D ;
Rossini, G ;
Boyce, B ;
Zhao, M ;
Gutierrez, G .
SCIENCE, 1999, 286 (5446) :1946-1949
[57]   Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women [J].
Orozco, P .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2004, 19 (12) :1105-1112
[58]   Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation - A possible explanation for the paradox of arterial calcification in osteoporotic patients [J].
Parhami, F ;
Morrow, AD ;
Balucan, J ;
Leitinger, N ;
Watson, AD ;
Tintut, Y ;
Berliner, JA ;
Demer, LL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (04) :680-687
[59]   High-density lipoprotein regulates calcification of vascular cells [J].
Parhami, F ;
Basseri, B ;
Hwang, J ;
Tintut, Y ;
Demer, LL .
CIRCULATION RESEARCH, 2002, 91 (07) :570-576
[60]   Role of lipids in osteoporosis [J].
Parhami, F ;
Garfinkel, A ;
Demer, LL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (11) :2346-2348